QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG
associated with 47 other trademarks
Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous s...

Words that describe this trademark:

central nervous system  peripheral nervous system  nervous system peripheral  pharmaceutical preparations  treatment prevention  system peripheral  preparations  prevention  therapeutic  humans 

Serial Number:

90287844

Mark:

QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

Status:

Abandoned-No Statement of Use filed

Status Date:

08-29-2022

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders; all containing Viloxazine

Mark Description:

The mark consists of the horizontally-situated literal element "QELBREE" with a diamond shape to the right of the last letter "E" of the literal element "QELBREE"; the literal element "VILOXAZINE" underneath "QELBREE"; the literal element "EXTENDED-RELEASE CAPSULES" underneath "VILOXAZINE"; and the literal element "100 MG 150 MG 200 MG" underneath "EXTENDED-RELEASE CAPSULES".

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

06-01-2021

Mark Drawing Status:

Design plus Words, Letters, and/or Numbers

Abandon Date:

08-29-2022

Business Name:

SAUL EWING ARNSTEIN & LEHR

Correspondent Name:

Recent Trademark filings by this company